Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatoid Arthritis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatoid Arthritis
    TopAbstracts in Rheumatoid Arthritis 11/26/2009 - (DGNews)
    TopAbstracts in Rheumatoid Arthritis 11/12/2009 - (DGNews)
    Anti-TNF Treatment Does Not Increase Cancer Risk in Patients With RA - (DGNews)
    TopAbstracts in Rheumatoid Arthritis 10/29/2009 - (DGNews)
    Tocilizumab Plus Methotrexate Provides Sustained Benefits in Patients With RA: Presented at ACR/ARHP - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatoid Arthritis
      Comorbidity in Patients with Rheumatoid Arthritis: What are the Real Concerns?
      Advances in Basic Science
      Quantitatively-Driven Management of Rheumatoid Arthritis
      Cancer, Liver, Infections, Cardiovascular Disease, and other Biologic Agents
      Rheumatoid Arthritis: Clinical Aspects, Outcomes, and Measures

      Webcasts/CME archive

       Recent cases - Rheumatoid Arthritis
        Mesenteric Rheumatoid Nodules Masquerading as an Intra-Abdominal Malignancy: A Case Report and Review of the Literature
        Co-Existence of Acute Myeloid Leukemia with Multilineage Dysplasia and Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis
        Patient with Hepatitis B and Rheumatoid Arthritis
        Complete Heart Block and Severe Aortic Stenosis in a Patient with Rheumatoid Arthtritis: A Case Report
        Limited Wegener's Granulomatosis Presenting as Lung Nodules in a Patient with Rheumatoid Arthritis: A Case Report

        Cases archive
          




        my personal edition > rheumatoid arthritis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Separate Treatments Strategies Needed for Disease Modifying Antirheumatic Drugs in Rheumatoid and Psoriatic Arthritis

        A DGReview of :"Original contribution : Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases"
        Zeitschrift für Rheumatologie

        05/12/2003
        By David Ball


        Patients with psoriatic arthritis (PsA) appear to have more side effects when treated with disease modifying antirheumatic agents (DMARDs) than do patients with rheumatoid arthritis (RA).

        These findings suggest that these two groups of patients require different treatment strategies, particularly when use of DMARDs is being considered, according to I. Ujfalussy and colleagues at the Polyclinic of the Hospitaller Brothers of St. John of God, Budapest, Hungary.

        Results of their study also suggest that earlier results seen on the safety of DMARDs in the treatment of RA "may not be directly applicable to PsA," they write.

        The researchers analysed the records of 102 RA and 104 PsA patients using Cox regression, life-table analysis and log rank test. They compared the effectiveness and toxicity as well as the duration of therapy with DMARDs in each patient group.

        Patients with RA were treated with gold sodium thiomalate (GST) for a median duration of 35 months, methotrexate (MTX) for 72 months and sulphasalazine (SSZ) for a median of 12 months. Those in the PsA group were treated with GST for a median of 12 months, MTX for 12 months and SSZ for 17 months.

        There was a statistically significant differences between GST and MTX (P=0.0043 and P=0.0447).

        Patients with PsA had more frequent rate of drug toxicity (P=0.0023) but no difference in efficacy was seen between groups.
        Z Rheumatol 2003 Apr;62:2:155-60. "Original contribution : Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send